Clinical Trial Update: Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLC [Phase 1]

View source ↗

Summary

This Phase I trial update describes two cisplatin-based regimens—vinorelbine plus cisplatin and gemcitabine plus cisplatin—for locally advanced or metastatic no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Gemzar (gemcitabine)
• Navelbine (vinorelbine)
• Platinol (cisplatin)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED